Article
miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
21 Jan 2014
Abstract excerpt
BACKGROUND: miR-200b has been reported to be a tumor suppressor and a promising therapeutic target in cancer. miR-200b has been associated with epithelial-mesenchymal transition and chemo-resistance in cancer. The aim of this study is to investigate the expression of miR-200b, its prognostic roles and its potential targets in breast cancer. METHODS: qRT-PCR was used to detect miR-200b expression in breast cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
